The Vaccine and Gene Therapy Institute at Oregon Health & Science University has assembled a multidisciplinary team of scientists to respond to serious viral disease threats, including AIDS, chronic viral infection-associated diseases, newly emerging viral diseases and infectious diseases of the elderly. Our programs are intended to span the continuum between basic and clinical science, in which discoveries are rapidly advanced from the level of molecular and cellular biology through animal models and ultimately into clinical testing. Learn more
VGTI Seminar Series and Virology Journal Club is now streamed online. Please reach out to Chad (email@example.com) if you would like a link to the live stream.
J Immunol. August 1, 2020
CTL clonotypes with higher TCR affinity have better ability to reduce the HIV latent reservoir
Front Immunol. June 2, 2020
Rapid Induction of multifunctional antibodies in rabbits and macaques by Clade C HIV-1 CAP257 envelopes circulating during epitope-specific neutralization breadth development
Science, May 20, 2020
SARS-CoV-2 infection protects against rechallenge in rhesus macaques
Methods Mol Biol, 2020
Analysis of Serum Anti-Zika Virus Antibodies by Focus Reduction Neutralization Test.